90,442 Shares of CME Group Inc. $CME Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. acquired a new position in CME Group Inc. (NASDAQ:CME) in the third quarter, HoldingsChannel reports. The fund acquired 90,442 shares of the financial services provider’s stock, valued at approximately $23,694,000.

Other hedge funds also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC grew its holdings in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares in the last quarter. First Community Trust NA purchased a new position in CME Group during the 3rd quarter valued at about $26,000. North Point Portfolio Managers Corp OH bought a new stake in shares of CME Group in the 3rd quarter valued at about $26,000. Main Street Group LTD bought a new stake in shares of CME Group in the 1st quarter valued at about $32,000. Finally, Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of CME Group in the 2nd quarter valued at about $28,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CME shares. Wells Fargo & Company upped their price target on shares of CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Saturday. Barclays lifted their price objective on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a report on Thursday, October 22nd. Morgan Stanley boosted their price objective on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Finally, Piper Sandler restated an “overweight” rating and set a $330.00 target price (up from $295.00) on shares of CME Group in a report on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $314.44.

CME Group Price Performance

Shares of CME stock opened at $306.24 on Tuesday. The stock’s 50-day moving average is $280.96 and its 200 day moving average is $280.20. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $110.12 billion, a P/E ratio of 25.12, a PEG ratio of 3.59 and a beta of 0.24.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The firm’s revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.68 earnings per share. Research analysts predict that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 42.66%.

Insider Transactions at CME Group

In other news, insider Sunil Cutinho sold 5,000 shares of CME Group stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total value of $1,493,500.00. Following the transaction, the insider owned 20,037 shares of the company’s stock, valued at $5,985,051.90. The trade was a 19.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the transaction, the insider owned 21,482 shares of the company’s stock, valued at approximately $6,555,232.30. This trade represents a 31.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 30,979 shares of company stock worth $8,946,762. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.